These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making]. Kakuda W; Abo M Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605 [TBL] [Abstract][Full Text] [Related]
7. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845 [TBL] [Abstract][Full Text] [Related]
8. [How did the results of ECASS II influence clinical practice of treatment of acute stroke]. Hacke W; Ringleb P; Stingele R Rev Neurol; 1999 Oct 1-15; 29(7):638-41. PubMed ID: 10599113 [TBL] [Abstract][Full Text] [Related]
9. Recent progress in drug treatment for acute ischemic stroke. Devuyst G; Bogousslavsky J Cerebrovasc Dis; 2001; 11 Suppl 1():71-9. PubMed ID: 11244203 [TBL] [Abstract][Full Text] [Related]